Regarding Target Exclusions for Performance Indices After Medical Fee Schedule Revision – PT-OT

News Highlights

PT-OT-ST.NET explains the target exclusions for performance indices in the FY2026 medical fee schedule revision. The importance of mid-to-long-term management and succession strategies with an eye on the revision cycle, the economies of scale through group participation (maintaining facility standards, dispersing equipment investment burdens), and consideration of tax schemes such as utilizing tax preferential treatment by transitioning to specific medical corporations or social medical corporations are raised as discussion points in M&A and business succession for medical institutions.

Perspective from M&A Medical Editorial Department

The specific indication of “target exclusions for performance indices” in this medical fee schedule revision holds significance beyond a mere regulatory change. In particular, the perspective of “mid-to-long-term management and succession strategies” with the revision cycle in mind is an urgent issue for healthcare facility managers. For instance, it is challenging for small clinics to maintain facility standards and disperse the burden of high-cost equipment investments independently. In such circumstances, M&A, which allows for enjoying economies of scale through group formation, can be an effective means not only to stabilize management but also to broaden future business succession options. Furthermore, utilizing tax schemes with a view to transitioning to specific medical corporations or social medical corporations can reduce the tax burden at the time of succession and promote smooth business succession. This revision suggests that it is a time to seriously consider M&A as “one of the options.”

Discussion Points Indicated by This News

• The “target exclusions for performance indices” in the medical fee schedule revision necessitates the rebuilding of management and succession strategies.
• Economies of scale through group formation directly lead to maintaining facility standards and dispersing equipment investment burdens.
• Considering tax schemes with a view to transitioning to specific medical corporations or social medical corporations is important.
• An aggressive M&A strategy that looks at the entire revision cycle is required.

Practical Questions Arising from This News

• What are the specific changes in medical departments and facility standards that will be subject to exclusion from performance indices?
• What kind of benefits in maintaining facility standards and equipment investments can be expected when forming a group?
• Under what conditions is it possible to transition to a specific medical corporation or social medical corporation, and what are the specific tax benefits?

If You Feel “Should I Consult Too?”

If you are concerned about how the trends of this medical fee schedule revision will affect your clinic’s management and future succession, now is the time to consider consulting. Especially if you want to conduct specific simulations regarding the maintenance of facility standards, the burden of equipment investment, and tax advantages or disadvantages, M&A specialists can propose optimal schemes including economies of scale through group formation and corporate status transitions. To broaden your options for future-oriented management and succession strategies, let’s hear from an expert once.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a complete success fee basis. We handle consultations with strict confidentiality. Free consultation here